Authors:
BERTRAND V
QUERE S
GUIMBAUD R
SOGNI P
CHAUVELOTMOACHON L
TULLIEZ M
LAMARQUE D
CHARREIRE J
GIROUD JP
COUTURIER D
CHAUSSADE S
BREBAN M
Citation: V. Bertrand et al., EFFECTS OF MURINE RECOMBINANT INTERLEUKIN-10 ON THE INFLAMMATORY DISEASE OF RATS TRANSGENIC FOR HLA-B27 AND HUMAN BETA-2-MICROGLOBULIN, European cytokine network, 9(2), 1998, pp. 161-170
Authors:
GUIMBAUD R
BEADES E
CHAUVELOTMOACHON L
QUARTIER G
GAUDRIC M
BERTRAND V
CELLIER C
VIDON N
DEVAUX JY
RICHARD B
COUTURIER D
CHAUSSADE S
Citation: R. Guimbaud et al., TECHNETIUM TC 99M HEXAMETHYL PROPYLENE AMINE OXINE LEUKOCYTE SCINTIGRAPHY IN PATIENTS WITH ULCERATIVE-COLITIS - CORRELATION WITH CLINICAL, BIOLOGIC, ENDOSCOPIC, AND PATHOLOGICAL INTENSITY, AND LOCAL RELEASE OFINTERLEUKIN-8, Gastrointestinal endoscopy, 48(5), 1998, pp. 491-496
Authors:
LAMRANI A
TULLIEZ M
CHAUVELOTMOACHON L
CHAUSSADE S
HAGNERE AM
VIDON N
Citation: A. Lamrani et al., OCTREOTIDE REGULATES INFLAMMATORY CYTOKINES IN THE EARLY PHASE OF CHRONIC EXPERIMENTAL COLITIS, Gastroenterology, 114(4), 1998, pp. 4168-4168
Authors:
BERTRAND V
GUIMBAUD R
SOGNI P
LAMRANI A
MAUPRIVEZ C
GIROUD JP
COUTURIER D
CHAUVELOTMOACHON L
CHAUSSADE S
Citation: V. Bertrand et al., ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INDUCIBLE NITRIC-OXIDE SYNTHASE IN THE PREVENTION OF NITRO-FLURBIPROFEN SMALL-INTESTINE TOXICITY, European journal of pharmacology, 356(2-3), 1998, pp. 245-253
Authors:
BERTRAND V
GUIMBAUD R
TULLIEZ M
MAUPRIVEZ C
SOGNI P
COUTURIER D
GIROUD JP
CHAUSSADE S
CHAUVELOTMOACHON L
Citation: V. Bertrand et al., INCREASE IN TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION LINKED TO THE TOXICITY OF INDOMETHACIN FOR THE RAT SMALL-INTESTINE, British Journal of Pharmacology, 124(7), 1998, pp. 1385-1394
Authors:
BERTRAND V
GUIMBAUD R
LAMRANI A
DELSOLDATO P
SOGNI P
MAUPRIVEZ C
GIROUD JP
COUTURIER D
CHAUVELOTMOACHON L
CHAUSSADE S
Citation: V. Bertrand et al., NITRIC OXIDE-RELEASING NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NO-NSAIDS) - A PROMISING APPROACH IN THE PREVENTION OF GASTROINTESTINAL TOXICITY INDUCED BY STANDARD NSAIDS, Gastroenterology, 112(4), 1997, pp. 933-933
Authors:
BERTRAND V
GUIMBAUD R
MAUPRIVEZ C
SOGNI P
GIROUD JP
COUTURIER D
CHAUSSADE S
CHAUVELOTMOACHON L
Citation: V. Bertrand et al., INVOLVEMENT OF TNF-ALPHA AND INDUCIBLE NOS IN THE PATHOGENESIS OF INDOMETHACIN-INDUCED INTESTINAL TOXICITY, Gastroenterology, 112(4), 1997, pp. 933-933
Authors:
GUIMBAUD R
ABITBOL V
BERTRAND V
QUARTIER G
COUTURIER D
GIROUD JP
CHAUVELOTMOACHON L
CHAUSSADE S
Citation: R. Guimbaud et al., LEUKEMIA INHIBITORY FACTOR (LIF) - A NEW CYTOKINE INVOLVED IN INFLAMMATORY BOWEL-DISEASE (IBD), Gastroenterology, 112(4), 1997, pp. 989-989
Authors:
QUERE S
BERTRAND V
TULLIEZ M
CHAUVELOTMOACHON L
CHARREIRE J
CHAUSSADE S
BREBAN M
Citation: S. Quere et al., THE EFFECTS OF A IL10 TREATMENT ON THE INFLAMMATORY BOWEL-DISEASE IN TRANSGENIC RATS EXPRESSING HLA-B27 AND HUMAN BETA-2-MICROGLOBULIN, Gastroenterology, 110(4), 1996, pp. 996-996
Authors:
BREBAN M
BERTRAND V
OERE S
TULLIEZ M
CHAUVELOTMOACHON L
CHAUSSADE S
Citation: M. Breban et al., IL-10 TREATMENT OF HLA-B27 TRANSGENIC RATS INHIBITS IFN-GAMMA EXPRESSION BUT DOES NOT AMELIORATE INFLAMMATORY DISEASE, Arthritis and rheumatism, 39(9), 1996, pp. 815-815
Authors:
GUIMBAUD R
CHAUVELOTMOACHON L
GIROUD JP
COUTURIER D
CHAUSSADE S
Citation: R. Guimbaud et al., ULCERATIVE-COLITIS IS AN OUTSTANDING DISEASE FOR THE NUMBER AND EXTENT OF INFLAMMATORY CYTOKINES LOCALLY PRODUCED, Gastroenterology, 108(4), 1995, pp. 829-829
Authors:
GIROUD JP
CHEN YL
LEVRAUX V
CHAUVELOTMOACHON L
Citation: Jp. Giroud et al., PHARMACOLOGICAL INTEREST OF ADENOSINE IN RELATION TO ITS ANTI-TNF PROPERTIES, Bulletin de l'Academie nationale de medecine, 179(1), 1995, pp. 79-101
Authors:
CHEN YL
LEVRAUX V
GIROUD JP
CHAUVELOTMOACHON L
Citation: Yl. Chen et al., ANTITUMOR NECROSIS FACTOR PROPERTIES OF NONPEPTIDE DRUGS IN ACUTE-PHASE RESPONSES, European journal of pharmacology, 271(2-3), 1994, pp. 319-327
Authors:
CHEN YL
LEVRAUX V
LENEVEU A
DREYFUS F
STHENEUR A
FLORENTIN I
DESOUSA M
GIROUD JP
FLOUVAT B
CHAUVELOTMOACHON L
Citation: Yl. Chen et al., ACUTE-PHASE RESPONSE, INTERLEUKIN-6, AND ALTERATION OF CYCLOSPORINE PHARMACOKINETICS, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 649-660